The early opinions that I was seeing were that the monoclonals weren’t thought to be effective against the two new variants and so were being held back.
I don’t know why that would be true, but I don’t understand how MAbs work, that’s above my pay grade. I just try to follow what’s going on with the medical types as best I can. Some of it I do know in detail, MAbs isn’t one of them. Maybe one of the docs can explain it.
I have heard that monoclonals are not effective (or as effective) against new variants, and I don’t think that is a contentious point.
I was using that to be inclusive of the approach to treating variants. I understand that monoclonals do have some effectiveness against the Delta variant.